Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies - ScienceDirect
Biologics in Psoriasis: The Next Generation - Practical Dermatology
Interleukin-17 – Wikipedia
The TNF/IL‐23/IL‐17 axis—Head‐to‐head trials comparing different biologics in psoriasis treatment - ten Bergen - 2020 - Scandinavian Journal of Immunology - Wiley Online Library
AxSpA: Was tun, wenn TNF-Inhibitoren versagen? | FAKTEN der Rheumatologie
Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review – JCAD | The Journal of Clinical and
Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies - ScienceDirect
Ixekizumab - 11 - 2016 - Heftarchiv - AMT
Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis | Arthritis Research & Therapy | Full Text
CIMB | Free Full-Text | The Treatment with Interleukin 17 Inhibitors and Immune-Mediated Inflammatory Diseases
Efficacy and safety of IL-17 inhibitors for the treatment of ankylosing spondylitis: a systematic review and meta-analysis | Arthritis Research & Therapy | Full Text
Frontiers | The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Paradoxe Krankheitsreaktionen von Biologika bei chronisch entzündlichen Systemerkrankungen
Frontiers | IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
Paradoxical gastrointestinal effects of interleukin-17 blockers | Annals of the Rheumatic Diseases
Biomedicines | Free Full-Text | Orchestrated Cytokines Mediated by Biologics in Psoriasis and Its Mechanisms of Action
IL-17 in Chronic Inflammation: From Discovery to Targeting - ScienceDirect
IL-17–targeting biologics aim to become standard of care in psoriasis | Nature Biotechnology
The role of interleukin-17 in asthma: a protective response? | European Respiratory Society
Gegen IL-17 oder gegen IL-23 gerichtetes Biologikum wählen? – Rosenfluh.ch
Local and systemic effects of IL-17 in joint inflammation: a historical perspective from discovery to targeting | Cellular & Molecular Immunology
Paradoxical gastrointestinal effects of interleukin-17 blockers | Annals of the Rheumatic Diseases
Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review – JCAD | The Journal of Clinical and
Psoriatic Arthritis and New First-Line Treatment Options: Interleukin-17 Inhibitors
IL-17 in Chronic Inflammation: From Discovery to Targeting: Trends in Molecular Medicine
IL-17 and IL-17-producing cells in protection versus pathology | Nature Reviews Immunology
New Biologics in Psoriasis: An Update on IL-23 and IL-17 Inhibitors | MDedge Dermatology
